Press-release for stocks for biontech se

for entities : Biontech se

save search

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNY | News | $46.615 -2.25% 730K

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.415 -7.12% 730K

Health Technology

| 0.0% | O: -5.77% H: 0.0% C: 0.0%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| 0.0% | O: 0.24% H: 0.0% C: 0.0%
business update for financial results

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
Published: 2024-04-07 (Crawled : 20:20) - globenewswire.com
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -0.83% | O: 1.38% H: 0.2% C: -1.27%
candidate cancer pancreatic tumor immunotherapy for response show

Kessler Topaz Meltzer & Check, LLP Investigates The Chemours Company for Potential Securities Violations and Encourages Investors to Contact Firm
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AMPL | $9.91 0.81% 63K

| -11.84% | O: 0.27% H: 0.54% C: -0.63%
CC | $27.13 1.5% 450K

Process Industries

| 2.34% | O: -0.34% H: 1.38% C: 0.27%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -8.11% | O: 0.54% H: 0.18% C: -1.13%
company potential

BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -3.05% | O: -0.19% H: 7.03% C: 5.71%

Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Amplitude, Inc. Investors in Securities Fraud Class Action Lawsuit
Published: 2024-02-28 (Crawled : 01:00) - prnewswire.com
AMPL | $9.91 0.81% 63K

| -18.08% | O: -1.08% H: 1.03% C: -0.93%
CMI | $293.75 0.36% 280K

Producer Manufacturing

| 9.0% | O: 0.09% H: 1.66% C: 0.59%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -4.63% | O: -1.2% H: 1.18% C: -0.27%
deadline

Archer-Daniels-Midland Company Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before March 25, 2024 to Discuss Your Rights - ADM
Published: 2024-02-15 (Crawled : 10:00) - prnewswire.com
BTAFF | $29.19 1.4K

Consumer Non-Durables

| -3.3% | O: -1.31% H: 4.06% C: 1.54%
BTI | $29.465 -0.32% 2.8M

Consumer Non-Durables

| -2.47% | O: 0.59% H: 0.52% C: 0.23%
ADM | $61.61 -0.29% 1.8M

Process Industries

| 15.99% | O: -0.02% H: 2.76% C: 1.97%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -3.25% | O: 0.2% H: 2.3% C: 1.39%
company

Final Deadline Approaching for Mercury Systems, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Mercury Systems, Inc. (MRCY) Investors of February 12, 2024 Lead Plaintiff Deadline
Published: 2024-02-08 (Crawled : 20:00) - prnewswire.com
MBLY | $31.06 2.07% 1.7M

| 15.09% | O: 1.13% H: 4.71% C: 3.63%
MRCY | News | $28.15 2.59% 190K

Electronic Technology

| 4.61% | O: 0.88% H: 10.92% C: 10.73%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -5.96% | O: -0.11% H: 0.0% C: -0.91%
deadline mercury

BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
Published: 2024-01-31 (Crawled : 12:00) - globenewswire.com
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -6.83% | O: -1.03% H: 2.91% C: 1.11%
bnt325 fda candidate designation

BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
Published: 2023-12-21 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $94.25 480

Health Technology

| -1.73% | O: -0.1% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K

Health Technology

| -3.51% | O: -0.08% H: 0.0% C: 0.0%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -13.92% | O: 0.67% H: 1.46% C: 0.08%
bnt323 fda candidate cancer designation therapy

Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | News | $290.34 340

Health Technology

| 1.77% | O: 0.39% H: 4.92% C: 1.52%
NVS | News | $98.1 0.84% 1.3M

Health Technology

| 5.79% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $148.515 -0.7% 4.3M

Health Technology

| -1.33% | O: 0.18% H: 0.0% C: 0.0%
ABBV | News | $168.21 -0.78% 1.2M

Health Technology

| 19.57% | O: -0.28% H: 0.0% C: 0.0%
GMAB | News | $28.22 -1.19% 240K

Health Technology

| -1.01% | O: 0.24% H: 3.44% C: 2.07%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -11.25% | O: -0.35% H: 3.09% C: 3.03%
financial results

BioNTech SE (BNTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Published: 2023-10-26 (Crawled : 21:00) - prnewswire.com
RCM | $11.935 1.57% 1.1M

Commercial Services

| 5.38% | O: 1.08% H: 0.62% C: -0.71%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -8.43% | O: 0.79% H: 0.36% C: -6.37%

Okta Inc. (OKTA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Published: 2023-10-26 (Crawled : 21:00) - prnewswire.com
RCM | $11.935 1.57% 1.1M

Commercial Services

| 5.38% | O: 1.08% H: 0.62% C: -0.71%
OKTA | $93.91 -0.49% 480K

Technology Services

| 39.39% | O: 0.74% H: 0.77% C: -1.64%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -8.43% | O: 0.79% H: 0.36% C: -6.37%

R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Published: 2023-10-26 (Crawled : 21:00) - prnewswire.com
RCM | $11.935 1.57% 1.1M

Commercial Services

| 5.38% | O: 1.08% H: 0.62% C: -0.71%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -8.43% | O: 0.79% H: 0.36% C: -6.37%

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M

Health Technology

| -14.35% | O: -0.39% H: 2.48% C: 1.8%
SNY | News | $46.615 -2.25% 730K

Health Technology

| -11.36% | O: 0.09% H: 0.0% C: 0.0%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -7.1% | O: 0.99% H: 1.81% C: 0.47%
covid-19 vaccine positive influenza topline program

BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $94.25 480

Health Technology

| -8.72% | O: 0.73% H: 0.0% C: -0.48%
SNY | News | $46.615 -2.25% 730K

Health Technology

| -10.11% | O: -0.69% H: 0.0% C: 0.0%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -2.66% | O: -2.24% H: 7.12% C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
Published: 2023-09-28 (Crawled : 17:00) - globenewswire.com
SNYNF | News | $94.25 480

Health Technology

| -12.73% | O: -2.28% H: 0.0% C: -0.06%
SNY | News | $46.615 -2.25% 730K

Health Technology

| -12.77% | O: -1.61% H: 0.0% C: 0.0%
BNTX | News | $88.185 -0.35% 140K

Health Technology

| -14.19% | O: 0.21% H: 0.04% C: -1.27%
covid-19 vaccine health authorization canada

Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
Published: 2023-09-11 (Crawled : 20:00) - biospace.com/
PFE | News 4 | $26.25 -0.27% 12M

Health Technology